Priyanka Barua, MD
Hematology/Oncology · Wilkes Barre
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 13
- 2 carriers
- Offices
- 2
Offices
2 locations · Geisinger Clinic · County of Santa Clara
Looking this up.
Hospitals listed: Geisinger Community Medical Center · Geisinger Medical Center · Geisinger Wyoming Valley Medical Center. That is not proof they admit you there this week.
Plans that list them
13 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Barua’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
13 of 13 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Geisinger Medical CenterDanville, PAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Geisinger, which runs 9 hospitalsPatients rate it 4 of 5 · 72% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 13.4 (11.4 to 15.7) · 748 cases, Jan 2024 – Dec 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.547, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.525, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.8 (0.6 to 0.9) · 1,370 cases, Jan 2024 – Dec 2024
- Geisinger Wyoming Valley Medical CenterWilkes Barre, PAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Geisinger, which runs 9 hospitalsPatients rate it 2 of 5 · 63% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 13.8 (11.1 to 17.1) · 426 cases, Jan 2024 – Dec 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.524, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.581, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.5 to 0.8) · 1,231 cases, Jan 2024 – Dec 2024
- Geisinger-Community Medical CenterScranton, PAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Geisinger, which runs 9 hospitalsPatients rate it 3 of 5 · 61% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.272, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.306, Oct 2024 – Sep 2025
See every measure and the patient survey for Geisinger Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 3 better, 4 the same, 1 worse of 8 measures. Readmissions: 0 better, 9 the same, 2 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (11.4 to 15.7) · 748 cases | Worse | Jan 2024 – Dec 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.547 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.525 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.6 to 0.9) · 1,370 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.82 (1.05 to 2.59) · 2,867 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.97 (0.75 to 1.18) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 208.1 (171.05 to 245.16) · 243 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.5 · 121 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.2 · 147 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.7 · 280 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.2 · 491 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.6 · 500 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.5 · 577 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 6,518 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0.02 to 0.37) · 11,450 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.03 to 0.38) · 11,860 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.81 (1.26 to 4.36) · 3,644 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.89 (0 to 2.16) · 1,657 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.25 (0.13 to 2.37) · 3,418 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.37 (4.5 to 12.24) · 1,638 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.36 (1.85 to 6.87) · 1,597 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.51 (0.22 to 2.81) · 907 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.97 (0.53 to 1.41) · 9,906 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.9 · 69 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.786 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.65 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.537 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.015 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.5 · 640 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 23.7 · 993 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 16 · 356 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 40.8 · 572 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 44.5 · 548 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.9 · 913 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.6 (3.5 to 6) · 748 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.6 · 67 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.5 · 164 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.6 · 356 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.6 (10.8 to 16.9) · 2,820 cases | No different | Jan 2022 – Dec 2024 |
What patients said (2,760 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 74% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 62% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 75% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 73% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 78% |
| Nurses "always" listened carefully | 80% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 72% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
See every measure and the patient survey for Geisinger Wyoming Valley Medical Center
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.8 (11.1 to 17.1) · 426 cases | Worse | Jan 2024 – Dec 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.524 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.581 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.5 to 0.8) · 1,231 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.91 (0.01 to 1.8) · 1,628 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.98 (0.72 to 1.24) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 170.97 (128.63 to 213.31) · 144 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.3 · 47 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.4 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.1 · 160 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.8 · 579 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 11.9 · 637 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.8 · 507 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,835 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.28 (0.1 to 0.46) · 9,458 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.07 to 0.43) · 9,682 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.6 (2.78 to 6.42) · 2,086 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.43 (0.02 to 2.84) · 867 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.17 (0.84 to 3.51) · 1,965 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.07 (4.74 to 15.4) · 846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.7 (2.42 to 8.97) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.82 (0.4 to 3.24) · 370 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.31 (0 to 0.82) · 8,252 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 26 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.573 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.64 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.744 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.6 · 233 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 23.2 · 944 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -30.1 · 165 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.6 · 668 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 27.4 · 659 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.6 · 1,004 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.2 (3 to 6) · 426 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.9 · 27 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.6 · 67 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.7 · 370 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.4 (10.2 to 17.5) · 1,042 cases | No different | Jan 2022 – Dec 2024 |
What patients said (1,592 patients answered, 21% of those asked)
| Cleanliness | 2 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 63% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 62% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 42% |
| "YES", patients would definitely recommend the hospital | 63% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Geisinger-Community Medical Center
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 2 better, 4 the same, 1 worse of 7 measures. Readmissions: 1 better, 8 the same, 2 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.272 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.306 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.21 (0.35 to 2.08) · 1,907 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1 (0.72 to 1.27) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 184.42 (136.36 to 232.47) · 130 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.5 · 81 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.7 · 216 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.4 · 159 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.6 · 463 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.5 · 690 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.5 · 322 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 4,346 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.35 (0.16 to 0.54) · 8,906 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.05 to 0.42) · 9,143 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.12 (2.25 to 6) · 1,927 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.26 (0 to 2.77) · 675 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.95 (0.55 to 3.34) · 1,826 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.95 (2.76 to 15.15) · 672 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.34 (2.9 to 9.79) · 637 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.75 (0.35 to 3.14) · 439 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.44 (0 to 0.97) · 7,749 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5 · 63 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.572 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.162 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.951 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 209 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 24.2 · 741 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -9.8 · 166 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 19.9 · 528 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 31.4 · 739 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19 · 983 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5 (3.5 to 7.2) · 162 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.8 (8.4 to 14) · 162 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.5 · 65 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.5 · 93 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 374 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12 (8.8 to 15.9) · 242 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.2) · 650 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,416 patients answered, 24% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 63% |
| Nurses "always" communicated well | 78% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 60% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 37% |
| "YES", patients would definitely recommend the hospital | 61% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
Original Medicare doctor bills
$32,261
Medicare paid this office $32,261 for 198 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 112 | $16,403 | $71 |
| New patient visit (60+ min) | 29 | $3,874 | $134 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 27 | $2,658 | $98 |
| Long return visit (40+ min) | 22 | $2,539 | $106 |
| Short return visit (20+ min) | 37 | $2,293 | $50 |
See all 7 services
| Return visit (30+ min) | 112 | $16,403 | $71 |
| New patient visit (60+ min) | 29 | $3,874 | $134 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 27 | $2,658 | $98 |
| Long return visit (40+ min) | 22 | $2,539 | $106 |
| Short return visit (20+ min) | 37 | $2,293 | $50 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 87 | $1,886 | $12 |
| New patient visit (45+ min) | 11 | $1,111 | $101 |
Who their Medicare patients are
198 Original Medicare patients in 2024. Average age 72 · Under 65 18% · 85 and older 11% · Women 66% · Also on Medicaid 19% · Health risk score 2.10. At or below the middle of the specialty; the typical medical oncology clinician is at 2.11.
Conditions among them: High blood pressure 75% · Cancer 68% · Chronic kidney disease 38% · Diabetes 33% · Coronary heart disease 32% · Depression 30% · Heart failure 25% · COPD 25% · Atrial fibrillation 20% · Stroke 8% · Dementia 6%.
The office billed $138,291, Medicare allowed $40,651 and paid $32,261; for 550 services of 13 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 198 | 550 | 72 | 2.10 | $138,291 | $32,261 |
| 2023 | 204 | 493 | 72 | 2.22 | $124,884 | $27,880 |
| 2022 | 82 | 127 | 71 | 1.61 | $40,964 | $10,373 |
| 2019 | 148 | 458 | 74 | 2.81 | $127,216 | $31,148 |
| 2018 | 259 | 893 | 75 | 2.59 | $254,993 | $67,090 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 6 services
| Short return visit (20+ min) | 120 | $13,763 | $46 |
| Return visit (30+ min) | 59 | $4,794 | $68 |
| New patient visit (45+ min) | 47 | $4,271 | $91 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 17 | $1,698 | $100 |
| Long return visit (40+ min) | 11 | $917 | $83 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 13 | $829 | $64 |
2022: 6 services
| New patient visit (60+ min) | 14 | $1,896 | $135 |
| Long return visit (40+ min) | 16 | $1,832 | $108 |
| Return visit (30+ min) | 22 | $1,774 | $77 |
| Short return visit (20+ min) | 23 | $1,597 | $52 |
| New patient visit (45+ min) | 15 | $1,595 | $106 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 11 | $861 | $78 |
2019: 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 117 | $16,716 | $62 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 27 | $4,642 | $172 |
| Hospital discharge day management, 30 minutes or less | 60 | $3,939 | $65 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 28 | $2,188 | $35 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 19 | $1,874 | $99 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 12 | $1,602 | $94 |
2018: 7 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 188 | $34,673 | $66 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 50 | $9,809 | $185 |
| Hospital discharge day management, 30 minutes or less | 113 | $7,825 | $66 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 44 | $5,910 | $123 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 33 | $3,117 | $36 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 21 | $2,345 | $94 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 19 | $2,275 | $95 |
Medicaid work
$12,323 in 2024
Medicaid paid $12,323 for 644 billed services this clinician did in 2024, up to 25 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 154 | $6,073 |
| Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour | 60 | $2,199 |
| Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug | 17 | $1,347 |
| COMPREHENSIVE METABOLIC PANEL | 148 | $1,270 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 169 | $735 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | 82 | $608 |
| Administration of influenza virus vaccine | 14 | $91 |
| 2024 | 644 | 7 | 25 | $12,323 |
| 2023 | 1,023 | 8 | 39 | $19,970 |
| 2022 | 150 | 5 | 26 | $4,478 |
| 2019 | 187 | 3 | 25 | $3,629 |
| 2018 | 180 | 2 | 16 | $3,176 |
See the largest Medicaid services in earlier years
2023
| Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug | 97 | $7,112 |
| Short return visit (20+ min) | 209 | $4,809 |
| Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour | 105 | $3,423 |
| COMPREHENSIVE METABOLIC PANEL | 292 | $2,390 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 256 | $1,006 |
| Return visit (30+ min) | 30 | $988 |
| Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular | 17 | $150 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) | 17 | $92 |
2022
| Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug | 37 | $3,216 |
| Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour | 13 | $387 |
| COMPREHENSIVE METABOLIC PANEL | 44 | $365 |
| Short return visit (20+ min) | 13 | $330 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 43 | $181 |
2019
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 128 | $2,749 |
| Hospital inpatient or observation discharge day management; 30 minutes or less on the date of the encounter | 28 | $544 |
| SBSQ HOSPITAL IP/OBS CARE SF/LOW MDM 25 MINUTES | 31 | $335 |
2018
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 165 | $2,926 |
| Hospital inpatient or observation discharge day management; 30 minutes or less on the date of the encounter | 15 | $250 |
Drugs they prescribed that Part D paid
$2,930,587
Pharmacies billed $2,930,587 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
428 generic and 207 brand-name prescriptions · $2,930,587 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ibrance | 37 | $571,856 | $15,456 |
| Lenvima | 12 | $299,791 | $24,983 |
| Mekinist | 17 | $263,435 | $15,496 |
| Verzenio | 17 | $253,658 | $14,921 |
| Lorbrena | 13 | $245,575 | $18,890 |
See all 19 drugs
| Ibrance | 37 | $571,856 | $15,456 |
| Lenvima | 12 | $299,791 | $24,983 |
| Mekinist | 17 | $263,435 | $15,496 |
| Verzenio | 17 | $253,658 | $14,921 |
| Lorbrena | 13 | $245,575 | $18,890 |
| Tafinlar | 17 | $242,286 | $14,252 |
| Piqray | 12 | $233,901 | $19,492 |
| Tagrisso | 12 | $206,969 | $17,247 |
| Nubeqa | 12 | $156,287 | $13,024 |
| Abiraterone Acetate | 54 | $150,425 | $2,786 |
| Eliquis | 30 | $23,028 | $768 |
| Anastrozole | 103 | $1,964 | $19 |
| Letrozole | 50 | $1,003 | $20 |
| Prochlorperazine Maleate | 20 | $492 | $25 |
| Prednisone | 46 | $321 | $7 |
| Dexamethasone | 24 | $283 | $12 |
| Ondansetron | 25 | $210 | $8 |
| Ondansetron Odt | 12 | $164 | $14 |
| Famotidine | 11 | $47 | $4 |
Year by year
| 2024 | 635 | 122 | None | 33% | $2,930,587 |
| 2023 | 522 | 113 | None | 27% | $1,970,914 |
| 2022 | 152 | 46 | None | 20% | $373,945 |
| 2021 | 114 | 23 | None | 29% | $597,803 |
| 2020 | 89 | 24 | None | 15% | $108,654 |
| 2019 | 54 | 22 | None | None | $219,374 |
| 2018 | 25 | 13 | 0% (0) | None | $3,024 |
| 2017 | 30 | None | 0% (0) | None | $230 |
| 2016 | 76 | 16 | 0% (0) | 17% | $5,188 |
| 2015 | 93 | 32 | 0% (0) | 28% | $4,927 |
| 2014 | 105 | 26 | None | 17% | $5,922 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 13 drugs
| Ibrance | 21 | $316,527 | $15,073 |
| Verzenio | 14 | $208,300 | $14,879 |
| Abiraterone Acetate | 45 | $128,666 | $2,859 |
| Eliquis | 21 | $14,475 | $689 |
| Exemestane | 12 | $3,228 | $269 |
| Anastrozole | 66 | $1,256 | $19 |
| Letrozole | 38 | $814 | $21 |
| Ondansetron | 36 | $393 | $11 |
| Prochlorperazine Maleate | 14 | $357 | $26 |
| Dexamethasone | 16 | $320 | $20 |
| Duloxetine | 20 | $316 | $16 |
| Prednisone | 37 | $189 | $5 |
| Gabapentin | 19 | $188 | $10 |
2022: 3 drugs
| Abiraterone Acetate | 11 | $45,944 | $4,177 |
| Anastrozole | 27 | $525 | $19 |
| Prednisone | 12 | $94 | $8 |
2021: 3 drugs
| Revlimid | 12 | $198,262 | $16,522 |
| Anastrozole | 19 | $463 | $24 |
| Prednisone | 12 | $107 | $9 |
2020: 2 drugs
| Anastrozole | 24 | $476 | $20 |
| Hydroxyurea | 13 | $130 | $10 |
Money from drug and device companies
$162 in 2025
| 2025 | 3 | 8 | None | $162 |
| 2024 | 2 | 2 | None | $42 |
| 2023 | 3 | 3 | None | $212 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Celgene | Reblozyl | $85 | 5 payments
|
| E.R. Squibb & Sons L.L.C. | Breyanzi | $48 | 2 payments
|
| Sobi | Vonjo | $29 | 1 payment
|
See all 8 published payments
| Celgene | Meals · 2025-12-02 | Reblozyl | $17 |
| Celgene | Meals · 2025-11-04 | Reblozyl | $17 |
| Sobi | Meals · 2025-09-15 | Vonjo | $29 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-07-16 | None | $22 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-06-11 | Breyanzi | $26 |
| Celgene | Meals · 2025-05-09 | Reblozyl | $17 |
| Celgene | Meals · 2025-04-02 | Reblozyl | $18 |
| Celgene | Meals · 2025-02-28 | Reblozyl | $17 |
See earlier years (2024, 2023)
2024: $42
| E.R. Squibb & Sons L.L.C. | Opdivo | $24 | 1 payment
|
| Celgene | Reblozyl | $18 | 1 payment
|
2023: $212
| GlaxoSmithKline | Jemperli | $97 | 1 payment
|
| Bayer Healthcare Pharmaceuticals | Xofigo | $96 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Opdivo | $19 | 1 payment
|
Professional record
- NPI
- 1649698440
- Licence
- PA MD478493
- Group
- Geisinger Clinic · County of Santa Clara
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RH0003X (207RH0003X); Student in a training program (390200000X)
- Mailing address
- 100 N Academy Ave, Danville, PA, 17822
- NPI first listed
- 2014-03-31
- NPI last updated
- 2022-08-26
- NPI record certified
- 2022-08-26
This is when the NPI record was last certified, not a medical board exam.